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Abstract
The prevalence of antibiotic resistant microbes has led to a call for new antibiotics
development. Due to the irresponsible practices of the medical community in prescribing
antibiotics, much of the demand for new antibiotics is suspect. I argue that the social
contract, which properly includes human relationships with laboratory animals, requires a
conservative attitude toward new antibiotics development. This attitude places limits on
the justificatory role of demand in determining whether a particular research project
meets the conditions for morally justified research, as defined by Rollin’s utilitarian
principle.

Identifying the Scope of the Problem
Antibiotic resistant microbes are a major public health concern, and medical practitioners
are currently calling for newer and more potent antibiotics, despite the scientific
challenges of developing these products and the low rate of return for pharmaceutical
companies. Many factors lead to the existence of antibiotic resistant microbes, and there
is significant empirical data suggesting that human prescribing practices are a major
contributor to this phenomenon. Laboratory animals endure great suffering and death in
order for antibiotic drugs to reach the market, and it seems that the pursuit of new
pharmaceutical products without comparable or even greater emphasis on changing
dysfunctional human activities is a violation of the social contract with animals. This
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contract is apparent in both the companion and husbandry sector of human-nonhuman
relationships, and properly belongs in the research arena as well.
In this paper, I will focus on a particular area of pharmaceutical research, the
development of new antibiotics. I will first present the theoretical background of the
argument that the social contract with companion and agricultural animals also applies to
laboratory animals, and that the social contract should include cultivation of a
conservative attitude toward using animal products. I will then provide empirical
evidence to support the claim that the demand for new pharmaceuticals is artificially
high, and that human behavior is a significant cause of the need for new antibiotics.
Finally, I will argue that the conservative attitude inherent in the social contract requires
us to make an effort to address the human causes of antibiotic resistant diseases, rather
than subjecting laboratory animals to painful and stress-inducing procedures in order to
meet this artificial demand for new antibiotics.

Pharmaceutical Research and the Utilitarian Principle
Bernard Rollin argues that laboratory animal research should conform to the utilitarian
principle, which requires that “the benefit to humans (or humans and animals) clearly
outweighs the pain and suffering experienced by the experimental animals.” 1 Rollin
states, however, that it is impossible to use the utilitarian principle in evaluating drug
research, as there is no way of knowing when a given chemical is likely to be of
therapeutic value. In this section, we will consider some implications of the utilitarian
principle in light of the statistical realities of antibiotics development and argue that the
utilitarian principle, although helpful, is not sufficient for evaluating the moral
appropriateness of antibiotic development research.
Despite the outcries of abolitionists, not all animal research is unjustifiable, and some
laboratory animal suffering is justified under ideal conditions.

Applying the utilitarian

principle to pharmaceutical research ought to require that we consider the extent to which
demand for new pharmaceuticals is artificially increased by the irresponsible practices of
both medical professionals and consumers, as assessing this factor is critical to evaluating
the legitimacy of the necessary animal suffering involved in new research projects. This

3

becomes difficult when evaluating the demand for new antibiotics, in light of the
prevalence of infectious diseases, which kill approximately 14 million people per year. 2
Many infectious diseases are exceedingly uncomfortable and lead to a significant amount
of human suffering. In addition, current literature indicates the proliferation of ever
stronger strains of microbes, many of which are resistant to all but the newest and
strongest antibiotics available. Thus, we are easily influenced by the reality of mass
human suffering associated with antibiotic resistant infections.
Although we are compelled to consider dysfunctional human behavior in evaluating
antibiotic development, it is not clear that we can do this effectively by applying the
utilitarian principle. The utilitarian principle does not allow for secondary considerations
such as the source of demand for a product. 3 By focusing on the balance between
suffering and likely benefit, the utilitarian principle is an effective way to limit research
to that which is truly necessary, but it fails to account for the dysfunctional causes of the
necessity that it evaluates. For example, the utilitarian principle might allow for
development of a new antibiotic to treat tuberculosis, provided that the benefit is likely to
exceed the animal suffering associated with the drug’s development. However, the
utilitarian principle lacks a mechanism for considering that a significant source of need
for new antibiotics to treat tuberculosis is human-caused. Many tuberculosis sufferers
fail to complete their treatment regiments as directed, leading to the need for a second
round of antibiotics that are much stronger. Inadequate exposure in the first treatment
cycle allows microbes to develop a resistance to the initial treatment regiment, and an
antibiotic resistant microbe is created. The utilitarian principle has no means for taking
facts of this sort into consideration.
We might also consider some implications of applying the utilitarian principle to
pharmaceutical research. Rollin cites statistics indicating that the ratio of beneficial
substances to substances that are tested ranges from one in ten thousand to one in one
hundred thousand. 4 Even a conservative estimate of one in five thousand indicates that
numerous instances of animal suffering and death are for no identifiable purpose, other
than the exceedingly unlikely possibility that testing will result in a marketable substance.
A .02% success rate does not seem to meet the requirements of the utilitarian principle,
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even without the additional considerations that we are suggesting. We have some reason
to believe that the utilitarian principle does support a significant reduction in
development of new antibiotics, simply due to the exceedingly unlikely possibility that
the associated suffering will lead to any measurable benefit.
It is noteworthy that a lack of basic understanding of infectious diseases has been cited as
a significant contributor to the lack of success in developing new antibiotics. 5 Most
currently used antibiotics were developed in the 1970’s, and no new class of antibiotics
was discovered during the 1970’s, ‘80s, and ‘90s. One hypothesis for resolving this issue
is that greater knowledge of systems biology would be helpful in improving this abysmal
record. Subjecting animals to painful testing procedures is difficult to justify when
researchers lack the relevant knowledge of infectious diseases that would make their
research more productive. Obtaining such knowledge would likely reduce the number of
failed drug trials, resulting in a net reduction in animal suffering and allowing some
pharmaceutical research to be justified by the utilitarian principle. Until such knowledge
is acquired, however, it is not clear what percentage of antibiotics research projects are
justified, regardless of the potential benefit that a particular project might have. It seems
that the utilitarian principle is somewhat inadequate in determining the moral
appropriateness of a particular research project, which leads to the necessity of the social
contract model in evaluating laboratory animal research.

The Social Contract and the Conservative Attitude
The social contract is significant in defining the parameters of appropriate treatment for
both companion animals and agricultural animals. It seems that the social contract
equally applies to laboratory animals, due to a similarly reciprocal relationship. The
social contract requires not only a certain level of treatment and respect for animals, but
also a conservative attitude toward use of animal products. In this section, we will
consider the feasibility of extending the social contract model to research animals, as well
as supporting the importance of the conservative attitude that we are advocating.
The social contract is relevant to human relationships with both companion and
agricultural animals. The social contract is essentially an agreement to treat others in a
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certain way provided we are treated the same way in return. 6 Although social contracts
between humans and animals are implicit, they remain morally relevant. In the case of
companion animals, human beings receive numerous benefits as a direct result of having
animals in their lives. Our pets comfort and console us, providing unconditional love that
few humans are capable of. The significance of this is well-documented, as companion
animals have been utilized in treatment of mental illnesses and credited with improving
quality of life for invalids and the elderly. This contribution is in addition to the more
conventional benefits that many of us experience as a result of having pets. The social
contract entails that because animals have given up their wild natures in order to live with
humans and provide benefits to us, we owe them a reciprocal degree of respect and
appropriate treatment.
The social contract is even more apparent, and perhaps more directly comparable to
laboratory animals, in the institution of animal agriculture. To state the nature of this
version of the social contract as basically as possible, “we (humans) take care of the
animals, and they take care of us.” This means that the sacrifices associated with
providing food, products, and a livelihood for humans necessarily entails a moral
obligation to the animals. Agricultural animals uphold their end of the social contract by
providing us with nutritious food and useful products. Our end of the social contract is to
provide for the well-being and basic interests of agricultural animals, including adequate
space, relevant enrichment, and attention to physical and psychological needs. 7
Both agricultural and companion animal relationships provide a comparable model for
the relationship between human beings and laboratory animals. In each of these arenas,
animals have equally given up their wild natures and submitted to less than ideal
conditions for the benefit of humans. Humans are obligated, by the social contract, to
make a concerted effort to meet the interests of the animals to the greatest extent possible.
Certain degrees of suffering and mistreatment are not acceptable for any reason under the
conditions of this contract. Laboratory animals “take care of us” by providing life-saving
and health improving products. In much the same way, companion and agricultural
animals provide a measureable benefit to humans. As the social contract model suggests,
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by choosing to have these types of relationships with animals, humans have entered into a
social contract that requires a certain degree of treatment and care.
The social contract requires that humans exhibit some degree of personal responsibility
for their choices. Rollin is highly critical of the current environment of irresponsible
behavior toward pet animals and the resulting social institutions, which implicitly support
an attitude of indifference toward animal interests. One such example of this institutional
support concerns the legislation designed to protect animals. Although strides have been
made, companion animals are still viewed primarily as property, and pet owners are
granted the discretion to do as they wish with their property. As a result, mutilation
procedures like declawing and ear clipping are commonplace, and there are no legal
repercussions for morally reprehensible acts like euthanizing a dog rather than paying to
board it while the owner is on vacation. These are clear examples of pet owners violating
the basic rights of companion animals for their own convenience. This lack of individual
responsibility toward companion animals represents a clear violation of the social
contract. Humans are failing miserably in upholding their half of the contract, treating
animals as mere property and means to our ends without regard for their most basic
interests.
The social contract also requires a conservative attitude toward the use of animal
products. A conservative attitude is a disposition of respect for animal sacrifices that
allow for certain products to be available, and a disvaluing of purposeless waste. The
historical tendency of Native Americans to use all parts of the buffalo, as well as showing
respect for the animal before killing it, is a paradigm example of this attitude (although
the historical accuracy of this depiction is somewhat suspect). Rollin’s discussion of the
importance of personal responsibility in caring for pet animals is another example of the
conservative attitude. The conservative attitude is equally present in the social contract
with agricultural animals. Throwing away beef that could easily be eaten or wasting eggs
on petty acts of vandalism, for example, would not be acceptable to most individuals who
recognize the social contract. If an animal suffers in order that we might benefit, it is
reasonable to claim that humans have a moral obligation to honor and respect this
sacrifice by not wasting animal products.
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The conservative attitude toward companion and agricultural animals that we have
identified is readily applicable to the social contract with laboratory animals that we are
suggesting. Consider the following example. A beef cow is born and raised for the
purpose of providing meat for humans. Inevitably, some suffering or discomfort is likely
in this animal’s life, despite our best effort to minimize such conditions. In addition, this
animal will eventually give its life so that we might live. This sacrifice requires humans
to be conscientious of our use of meat. It would not be justifiable to increase meat
production simply so that humans could waste meat products haphazardly. What reason
could we possibly give for facilitating such a practice? Certainly any reason that might
be offered would seem superficial and inadequate in light of the requisite animal
suffering involved. Analogously, a lab mouse might spend its natural life having new
antibiotics tested on it. This animal will also experience suffering despite our best effort
to minimize such conditions. Ultimately the animal will die, often at the conclusion of a
research project and possibly as a direct result of the products tested upon it. This animal
has also made the “ultimate sacrifice” in order to benefit humans. If we would not be
justified in increasing meat production to facilitate irresponsible human behavior, it
follows that we should not increase pharmaceutical testing in order to facilitate
irresponsible behavior. Such actions would equally represent a violation of the social
contract with animals, and a failure to embrace the conservative attitude that the social
contract requires.

The Problem of Antibiotic Resistant Microbes
Antibiotic resistant microbes are an increasingly significant concern in the medical
community, and medical practitioners are calling for newer and more potent antibiotics.
A brief review of the problem is therefore necessary if we are to understand the tendency
to justify all antibiotic development research as necessary and the challenges associated
with rejecting this justification.
Concerns regarding antibiotic resistance emerged in the late 1990s, 8 and it is typically
cited as a major concern for medical practitioners. Current statistics conclude that up to
70% of all infectious bacteria are resistant to at least one commonly prescribed antibiotic,
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and resistance is predicted to increase at 4% to 7% per year. This problem is especially
significant in the developing world, where it is often difficult to acquire large quantities
of newer antibiotics. This is compounded by the exceedingly difficult nature of antibiotic
development, and the fact that many pharmaceutical companies to do not invest heavily
in the development of new antibiotics, due to the low rate of return compared with drugs
designed to treat long-term illnesses.
Despite these challenges, many new antibiotics are being developed, with 7 new drugs
receiving FDA approval in 2005, out of 81 approvals that same year. In addition,
approximately 18 new antibacterials are currently being tested. These numbers seem
insignificant until we consider the conservatively estimated success rate of .02% cited
earlier. The 7 drug approvals from 2005 are the result of 35,000 substances tested, while
the 18 drugs currently in clinical trial might have as many as 90,000 unmarketable
substances in their histories. Based on the significant need for better antibiotics,
however, many researchers are calling for new drugs to be developed despite these
technical challenges. 9
This cry for help is potentially problematic in light of the necessary animal suffering
involved with such development activities and the well-documented correlation between
medical practices, patient expectations, and overprescription of antibiotics. An analysis
of the irresponsible human practices fueling the need for newer antibiotics indicates that,
although the current situation is somewhat supportive of a push for new antibiotics, much
of the demand for stronger drugs is artificially enhanced and not morally justifiable.

The Case for Human Behavior as a Cause of Artificial Demand
There is a significant body of research which supports the claim that human practices of
antibiotic prescription are excessive and dysfunctional, and that this is a significant
contributor to the emergence of antibiotic resistant diseases, as well as a driving force in
the call from the medical field for newer and more potent antibiotics. Establishing that
the demand for new antibiotics is artificially high requires that we draw a correlation
between antibiotic resistance and dysfunctional human behaviors. A majority of research
concerning the problem of overprescription centers around the habits and attitudes of
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medical practitioners, but a small percentage of this literature also considers the role of
patient expectations as a relevant contributor to this issue. We will consider this minority
cause before turning to the role of physician behavior as the primary source of artificial
demand for antibiotics.
There is much evidence to support the claim that patient expectations are a significant
contributor to the overprescription problem. The most common manifestations of this
problem are patient pressure exerted on doctors, 10 patient assumptions that new and
innovative antibiotics are always better and therefore desirable, 11 and patient failure to
follow treatment protocols. 12 A 2007 survey of practitioners in Ireland supports the
claim that patient behaviors are a contributing factor to overprescription of antibiotics,
citing 54.7% of respondents who strongly agreed with the claim that patients often expect
a prescription for antibiotics, even when inappropriate. 22.7% of responding physicians
reported feeling under pressure to prescribe antibiotics for patients. 13 This suggests that
patients are not only making it clear that they expect to be given antibiotics, but that
doctors are somewhat influenced by this expectation.
Additional data also supports the claim that this pressure from patients is having an effect
on doctor prescribing patters. A 2007 article in Pharmacotherapy cited data from a
survey of British patients with respiratory conditions, 72% of whom reported expecting
antibiotic therapy. The physicians who prescribed antibiotics reported that antibiotic
therapy was only clinically indicated in 20% of the surveyed patients. Another 20% of
prescribing physicians reported writing a prescription in order to get the patient out of the
office, rather than out of clinical necessity. 14 It seems that patients seeking medical care
have certain expectations for treatment, and physicians are responding in an effort to
placate them. Not only is this problematic in light of the emerging problem of antibiotic
resistance, it is also a violation of the social contract with laboratory animals that we are
advocating. Reckless use of valuable medicines is not consistent with the conservative
attitude required by the social contract, and statistical data provided supports the claim
that a significant amount of current antibiotics use is frivolous, unnecessary, and
responsive to dysfunctional social norms concerning medical care. It would seem
difficult to justify the development of new antibiotics without first addressing these
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irresponsible social behaviors, and their measurable impact supports our claim that much
of the demand for new antibiotics is artificial.
If the problem of overprescription is to be addressed realistically, medical practitioners
must also be held accountable for their contribution to this growing concern. To some
extent, the previously discussed problem of patient expectations is properly a problem
with practitioners as well. As professionals, their own ethic should require them to make
responsible decisions, regardless of patient expectations which are often naïve and
uninformed. However, in an environment of fee-for-service medical care, it is difficult to
remain unreceptive to patient expectations. The line between patient and customer is
blurry, making it difficult to separate between doing what is medically- indicated and
satisfying the customer.
Economic concerns aside, there are several prominent causes of overprescribing
antibiotics that are more directly related to physician protocols. The Journal of the
Canadian Medical Association cites four causes of inappropriate prescribing behaviors
among physicians. Lack of physician knowledge, lack of experience, training
environment that supports overprescribing, and avoidance of time-consuming patient
education are all significant contributors to the problem of overprescribing antibiotics. 15
These essentially break down into two categories: ignorance of relevant data, and
influence of external factors.
Ignorance-based causes of overprescribing are perhaps the easiest to resolve. Lack of
experience with prescribing is something of an unavoidable phenomenon, although the
minimal time invested by medical schools to educate their students on responsible
treatment protocols is a contributing factor, 16 and adequate supervision of new physicians
would likely alleviate most of this problem. The greater concern in this category is the
problem of genuine ignorance about proper prescribing protocols among knowledgeable
medical professionals. One source of this ignorance is poor judgment of treatment
outcomes. 17 Many physicians are not very good at knowing what treatment is likely to
succeed, so they err on the side of caution and prescribe antibiotics. Other sources of
genuine ignorance among physicians include not understanding what treatment protocols
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are appropriate. For example, despite numerous studies supporting the conclusion that
antibiotics are not effective in treatment of the common cold, antibiotics are regularly
prescribed for cold sufferers. 18 This practice remains dangerously typical despite the
obvious common-sense conclusion that antibacterials are not an effective treatment for a
viral infection, which common colds tend to be. Improper prescribing behavior of this
kind is caused by physician reliance on outdated information, fear of undertreatment, and
misguided beliefs. 19 The belief that antibiotics will not hurt but may help is especially
problematic, as it clearly represents a lack of understanding of the problem of
overprescription, as well as a failure to display the conservative attitude that the social
contract requires.
Physicians are not solely responsible for the phenomenon of overprescription, and the
irresponsible behavior of physicians is often externally influenced. We have already
mentioned the influence of patient expectations and economic considerations. We might
also mention one of the cited hypotheses that antibiotics are prescribed in order to avoid
time-consuming patient education. This is symptomatic of the nature of our medical
system, which focuses on economic goals rather than optimal treatment protocols. Many
physicians are evaluated and paid at a piecemeal rate, and their self-interest motivates
them to maximize the number of patients seen per day. In addition, patient expectations
require that medical practitioners explain complicated medical scenarios to individuals
who may not be well equipped to understand, and in a manner that is sufficient to
overcome a patient’s preconceived notion of what is necessary. Quite simply, it is easier
to write a prescription than it is to engage in this trying educational endeavor.
The most significant external influence on physician prescribing behaviors is that of the
pharmaceutical industry itself. Due to the challenges of keeping physicians up to date on
the latest medical research on pharmaceuticals, many physicians get a large portion of
their continuing education directly from pharmaceutical representatives. In addition, the
close relationship between the industry and individual physicians can lead to a conflict of
interest. Many physicians receive personal benefits from prescribing as many antibiotics
as possible, with higher compensation rates for new antibiotics. Finally, the prevalence
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of pharmaceutical advertising supports patient attitudes that antibiotic treatment is always
preferable, and that unnecessary prescriptions do no harm.
There are many additional issues that contribute to the problem of overprescribing
antibiotics. Our intention is simply to illustrate that the demand for new antibiotics is
being affected by a wide variety of dysfunctional practices of both physicians and
patients, and that the demand for new antibiotics is therefore somewhat artificial. Much
like the problems associated with companion animal treatment, many irresponsible
individual activities in the medical field are being buttressed by the social institution of
overprescription. Just as animal shelters should be utilized conservatively so as to
prevent reinforcing dysfunctional attitudes toward companion animals, development of
new antibiotics should also be conservatively approached so as to encourage selfcorrection of these problems and prevent the unjustified suffering of laboratory animals
that would be necessary if the artificially high demand for new antibiotics were to be met.

Application of the Formal Argument
We have thus far presented the philosophical background supporting an extension of the
social contract to research animals and argued that the social contract necessitates a
conservative attitude toward the use of animal products. We have utilized relevant
empirical data to support the claim that the demand for new antibiotics is artificially
enhanced by irresponsible human behaviors. We now turn to a formalization of our main
argument in an effort to clarify its conclusions.
The following represents the argument presented in a basic format:
1) The social contract requires a conservative attitude towards use of products that
rely on animals, directly or indirectly, for their development.
2) Personal and professional responsibility are important features of this
conservative attitude, and failure to act as such is a violation of the social contract.
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3) Demand for a product that is artificially increased by irresponsible human
behaviors does not provide sufficient justification for animal suffering.
4) The demand for new antibiotics has been artificially increased by irresponsible
human behaviors, which manifest in the practice of overprescription.
5) From 3 and 4, animal suffering for the purpose of developing new antibiotics is
not justified solely by reference to the demand for new antibiotics.
6) From 2 and 4, the call for new antibiotics and the practice of overprescription do
not reflect the conservative attitude of personal and professional responsibility
that is an important feature of the social contract.
7) From 1 and 6, the call for new antibiotics and the practice of overprescription are
violations of the social contract.
Premise 1 assumes that the social contract applies to laboratory animals and that the
conservative attitude is a key component of the social contract, as we argued earlier.
Premise 2 is an articulation of what the conservative attitude entails and is based on
extending Rollin’s claims regarding personal responsibility and companion animals to
other areas of human-nonhuman relationships. Premise 3 is perhaps the most
controversial, relying on the content of Premises 1 and 2 in order to support the notion
that personal responsibility and the social contract do not allow for demand to be
haphazardly referenced as justification for certain actions that cause harm. Premise 3
also relies on common-sense notions of how valuable products should and should not be
used. Inclusion of the term “sufficient” is significant, and is intended to limit the
influence of artificial demand for antibiotics without eliminating the relevance of
legitimate demand. The claim is simply that demand alone, if it is artificially enhanced,
does not morally justify testing new antibiotics on animals. Premise 4 is based on the
empirical data presented which supports the claim that dysfunctional human behavior is
increasing the need for new antibiotics. We are left with three relatively uncontroversial
conclusions, namely that animal suffering for the purpose of developing new antibiotics
is not justified solely by reference to demand, that the call for new antibiotics and the
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practice of overprescription are not consistent with the conservative attitude properly
associated with the social contract, and that the call for new antibiotics and the practice of
overprescription are violations of the social contract with research animals.
We should note that this argument does not lead to the conclusion that no new antibiotics
can ever be developed. Our claim is simply that the appropriate conservative attitude
toward antibiotic development, as necessitated by the social contract, does not allow us to
justify developing new antibiotics solely on the basis of demand, since much of the
demand is artificially influenced by irresponsible human behaviors. At an absolute
minimum, efforts should be made to address the problem of dysfunctional human
behaviors before substantial investment in antibiotic development is undertaken.
Antibiotic development is becoming increasingly difficult from a scientific standpoint,
and it is in our interest to curtail the wasteful practices of patients and physicians so that
future new antibiotics are not wasted without maximizing the utility of their potential.
Animal interests aside, we have good pragmatic reasons to adopt the conclusions of this
argument. We also have good reasons, from the standpoint of animal rights, to adopt the
conservative attitude necessitated by the social contract and apply it to evaluating new
antibiotics development projects.

Conclusion
In the case of developing new antibiotics, once we incorporate the appropriate
conservative attitude required by the social contract, the utilitarian principle does support
a reduction in research on new antibiotics, at least until the problems of overprescription
are addressed. The challenge of applying the utilitarian principle in this area is that we
are tempted to justify a great deal of suffering in order to allow for significant
breakthroughs to take place. This is not surprising in light of the prevalent devastation of
infectious diseases worldwide. However, based on the empirical data presented, the
conservative attitude required by the social contract makes it difficult to justify a good
deal of suffering that the utilitarian principle might have allowed us to overlook.
Although the utilitarian principle is an important starting point for evaluating research,
we should also consider the source of demand for new antibiotics by applying the

15

conservative attitude of the social contract. This will result in more stringent criteria for
morally justifiable antibiotics development research that utilizes animal testing,
protecting laboratory animals from unjustifiable suffering. It will also force both
consumers and medical practitioners to be more cautious in their attitudes toward
appropriate use of antibiotics. By adopting the conservative attitude, both human and
non-human may benefit.
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